Capital Flow Monitor · Sponsors · CIK 1904099

OrthoBio Therapeutics, Inc.

1300 N. Frontage Road, #5937, Vail, CO, 81657 · 970-376-8517

Biotechnology · Corporation· inc. DELAWARE true

Fit score

Offering

$31.4M

Sold

$31.4M

% sold

100.0%

Investors

45

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2025-07-02 D ·current 506(b) $31.4M $31.4M 100.0% 45 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed.

  • Peter J. Millett — Executive Officer / Director, Vail, CO
  • Marc Prisant — Executive Officer, Vail, CO
  • Lodewijk de Vink — Director, Vail, CO
  • William T. Esrey — Director, Vail, CO
  • Jessica Hopfield — Director, Vail, CO
  • Robert Hugin — Director, Vail, CO
  • Stanley Shuman — Director, Vail, CO

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.